Table 2.
Clinicopathological characteristics of primary hepatocellular carcinoma patients.
| Caveolin-1 | |||||
|---|---|---|---|---|---|
| Parameters | Variable | No. of patients | (+) | % | p* |
| Gender | Male | 80 | 53 | 66.3 | 0.833 |
| Female | 15 | 9 | 60 | ||
| Tumor size | < 5 cm | 78 | 51 | 65.4 | 0.833 |
| > 5 cm | 17 | 11 | 64.7 | ||
| Etiology | Hepatitis viruses | 79 | 52 | 65.8 | 0.601 |
| Non-viral | 11 | 7 | 63.6 | ||
| Unknown | 5 | 3 | 60 | ||
| Number of tumor nodules | < 3 | 43 | 29 | 67.4 | 0.580 |
| > 3 | 52 | 33 | 63.5 | ||
| Venous invasion | Present | 38 | 29 | 76.3 | 0.02** |
| Absent | 57 | 33 | 57.9 | ||
| Tumor grade (a) | Well differentiated | 18 | 8 | 44.4 | < 0.001** |
| Moderately differentiated | 60 | 39 | 65.0 | ||
| Poorly differentiated | 17 | 15 | 88.2 | ||
* X2, ** Statistically significant
(a) All of the HCC tissues used in this study are in a cirrhotic background.